when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Monoclonal Antibody · news · pharmadog

← back to Monoclonal Antibody

News · Monoclonal Antibody

553 stories

Aug 13, 26Taiho and Cullinan’s zipalertinib clears Phase 3, teeing up first-line competitionbiospace

Aug 13, 26Chutes & Ladders—Former Legend CEO lands at K2fiercebiotech

Aug 13, 26PDS halts work on phase 3 cancer therapy to focus on colorectal contenderfiercebiotech

Aug 13, 26Behind the bell: Gearing up to go publicbiospace

Aug 13, 26Recon: FDA grants Concerta generic withdrawal hearing; Ivonescimab wins first-line NSCLC nod in Chinaraps

Aug 12, 26STAT+: Cancer patients face longer wait times to begin treatment, according to new studystat

Aug 12, 26Silence cashes in on ‘differentiated’ data; UK reaffirms support for childhood vaccinesbiopharma dive

Aug 12, 26STAT+: Definium Therapeutics says its LSD therapy eased anxiety in late-stage trialstat

Aug 12, 26Boulevard starts up with $65M to pursue targeted autoimmune drugsbiopharma dive

Aug 12, 26STAT+: Biotech company co-founded by top autoimmune researcher lays out plans with antibody therapiesstat

Aug 11, 26CytoDyn’s leronlimab reaffirms HIV potential after combo treatment eradicates virus in infant macaquesfiercebiotech

Aug 11, 26Opinion: Trump says his executive order should restore trust in vaccines. It does the exact oppositestat

Aug 11, 26Ex-Legend CEO takes helm at biotech startup scouring the globe for drugsbiopharma dive

Aug 11, 26Building Resilience for the Future of Biopharma Innovationfiercebiotech

Aug 11, 26Chasing Dupixent, a biotech aims to make better antibody drugs for eczemabiopharma dive

Aug 11, 26Deerfield-backed Boulevard Bio embarks on ‘beautiful path to a cure’ with trio of immunology drugsfiercebiotech

Aug 11, 26Epicrispr, Infinimmune snag combined $165M in VC cashbiospace

Aug 11, 26AbCellera’s menopause medicine ‘sets new efficacy bar’ for hot flashesbiospace

Aug 11, 26Silence causes uproar in rare blood cancer space as data sets high bar for competitorsbiospace

Aug 11, 26Epicrispr raises $90M to rewrite treatment of rare muscle diseasefiercebiotech

Aug 11, 26After tasting IPO success, Hemab’s CEO seeks ‘flavor of a multi-product coagulation company’fiercebiotech

Aug 10, 26BMS picks Texas for new $2.3B manufacturing campusbiospace

Aug 10, 26Regeneron backs $75M series A for antibody upstart Infinimmunefiercebiotech

Aug 10, 26Jazz commits up to $1.3B to buy Actio, bolster epilepsy pipelinebiospace

Aug 10, 26‘We are proud to be in the lead’: Vaderis lands $152M for phase 3 study in rare blood vessel disorderfiercebiotech

Aug 10, 26Scholar Rock ditches Novo’s legacy Catalent plant in FDA refiling of SMA drugfiercebiotech

Aug 10, 26Opinion: We prepared for Ebola — but not this Ebolastat

Aug 10, 26Opinion: We prepared for Ebola — but not this Ebolastat

Aug 10, 26AbCellera women’s health data top ‘most aggressive upside scenario,’ putting Astellas and Bayer on noticefiercebiotech

Aug 10, 26Sobi pens $580M deal for Innate’s skin cancer drug ahead of phase 3 pushfiercebiotech

← prevpage 9 of 19next →